Global 3D Bioprinting for Tissue and Organ Regeneration Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028
Report Code: KNJ1082398 No. of Pages: 100 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global 3D Bioprinting for Tissue and Organ Regeneration market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.
This report studies the 3D Bioprinting for Tissue and Organ Regeneration market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of 3D Bioprinting for Tissue and Organ Regeneration in these regions, from 2017 to 2028, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Magnetic 3D Bioprinting
Laser-assisted Bioprinting
Inkjet 3D Bioprinting
Microextrusion 3D Bioprinting
Market Snapshot, By Application
Clinical Applications
Research Applications
Drug and Medical Research
Others
Main Market Players Analyzed in this report, including:
BIOLIFE4D
TRS – Tissue Regeneration Systems
TeVido Biodevices
T&R BIOFAB
Rokit
REGEMAT 3D
Poietis
Organovo
Nscrypt, Inc
Nano3D Sciences
MedPrin
EnvisionTEC
Digilab
Cyfuse Biomedical
Celllink
Cellbricks
Aspect Biosystems
Allevi
Advanced Solutions Life Sciences
The study objectives of this report are:
To study and analyze the global 3D Bioprinting for Tissue and Organ Regeneration market size (Million USD) by company, key regions/countries, products and application, history data from 2017 to 2021, and forecast to 2028.
To understand industry structure of 3D Bioprinting for Tissue and Organ Regeneration market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global 3D Bioprinting for Tissue and Organ Regeneration manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the 3D Bioprinting for Tissue and Organ Regeneration market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of 3D Bioprinting for Tissue and Organ Regeneration submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of 3D Bioprinting for Tissue and Organ Regeneration are as follows:
History Year: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Year 2023 to 2028
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2021 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 3D Bioprinting for Tissue and Organ Regeneration Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global 3D Bioprinting for Tissue and Organ Regeneration Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and 3D Bioprinting for Tissue and Organ Regeneration
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Clinical Applications
3.2.2 Major Buyers in Research Applications
4 Market Segment: by Type
4.1 3D Bioprinting for Tissue and Organ Regeneration Type Introduction
4.1.1 Magnetic 3D Bioprinting
4.1.2 Laser-assisted Bioprinting
4.1.3 Inkjet 3D Bioprinting
4.1.4 Microextrusion 3D Bioprinting
4.2 Global 3D Bioprinting for Tissue and Organ Regeneration Revenue by Type 2017-2022
5 Market Segment: by Application
5.1 3D Bioprinting for Tissue and Organ Regeneration Type Introduction
5.1.1 Clinical Applications
5.1.2 Research Applications
5.1.3 Drug and Medical Research
5.1.3 Others
5.2 Global 3D Bioprinting for Tissue and Organ Regeneration Revenue by Application 2017-2022
6 Marke Segment: by Region
6.1 Global 3D Bioprinting for Tissue and Organ Regeneration Market by Region
6.2 North America 3D Bioprinting for Tissue and Organ Regeneration Market 2017-2022
6.3 Europe 3D Bioprinting for Tissue and Organ Regeneration Market 2017-2022
6.4 Asia Pacific 3D Bioprinting for Tissue and Organ Regeneration Market 2017-2022
6.5 South America 3D Bioprinting for Tissue and Organ Regeneration Market 2017-2022
6.6 Middle East and Africa 3D Bioprinting for Tissue and Organ Regeneration Market 2017-2022
7 North America
7.1 North America 3D Bioprinting for Tissue and Organ Regeneration Market by Country 2017-2022
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe 3D Bioprinting for Tissue and Organ Regeneration Market by Country 2017-2022
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific 3D Bioprinting for Tissue and Organ Regeneration Market by Country 2017-2022
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America 3D Bioprinting for Tissue and Organ Regeneration Market by Country 2017-2022
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa 3D Bioprinting for Tissue and Organ Regeneration Market by Country 2017-2022
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 BIOLIFE4D
12.1.1 BIOLIFE4D
Company Information
12.1.2 BIOLIFE4D
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.1.3 BIOLIFE4D
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.1.4 BIOLIFE4D
Key Development
12.2 TRS – Tissue Regeneration Systems
12.2.1 TRS – Tissue Regeneration Systems
Company Information
12.2.2 TRS – Tissue Regeneration Systems
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.2.3 TRS – Tissue Regeneration Systems
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.2.4 TRS – Tissue Regeneration Systems
Key Development
12.3 TeVido Biodevices
12.3.1 TeVido Biodevices
Company Information
12.3.2 TeVido Biodevices
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.3.3 TeVido Biodevices
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.3.4 TeVido Biodevices
Key Development
12.4 T&R BIOFAB
12.4.1 T&R BIOFAB
Company Information
12.4.2 T&R BIOFAB
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.4.3 T&R BIOFAB
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.4.4 T&R BIOFAB
Key Development
12.5 Rokit
12.5.1 Rokit
Company Information
12.5.2 Rokit
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.5.3 Rokit
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.5.4 Rokit
Key Development
12.6 REGEMAT 3D
12.6.1 REGEMAT 3D
Company Information
12.6.2 REGEMAT 3D
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.6.3 REGEMAT 3D
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.6.4 REGEMAT 3D
Key Development
12.7 Poietis
12.7.1 Poietis
Company Information
12.7.2 Poietis
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.7.3 Poietis
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.7.4 REGEMAT 3D
Key Development
12.9 Nscrypt, Inc
12.9.1 Nscrypt, Inc
Company Information
12.9.2 Nscrypt, Inc
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.9.3 Nscrypt, Inc
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.9.4 Nscrypt, Inc
Key Development
12.8 Organovo
12.8.1 Organovo
Company Information
12.8.2 Organovo
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.8.3 Organovo
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.8.4 Organovo
Key Development
12.11 MedPrin
12.11.1 MedPrin
Company Information
12.11.2 MedPrin
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.11.3 MedPrin
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.11.4 MedPrin
Key Development
12.12 EnvisionTEC
12.12.1 EnvisionTEC
Company Information
12.12.2 EnvisionTEC
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.12.3 EnvisionTEC
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.12.4 EnvisionTEC
Key Development
12.13 Digilab
12.13.1 Digilab
Company Information
12.13.2 Digilab
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.13.3 Digilab
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.13.4 Digilab
Key Development
12.14 Cyfuse Biomedical
12.14.1 Cyfuse Biomedical
Company Information
12.14.2 Cyfuse Biomedical
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.14.3 Cyfuse Biomedical
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.14.4 Cyfuse Biomedical
Key Development
12.15 Celllink
12.15.1 Celllink
Company Information
12.15.2 Celllink
3D Bioprinting for Tissue and Organ Regeneration Product Portfolio, Specification and Application
12.15.3 Celllink
3D Bioprinting for Tissue and Organ Regeneration Revenue and Gross Margin (2019-2021)
12.15.4 Celllink
Key Development
12.17 Aspect Biosystems
12.18 Allevi
12.19 Advanced Solutions Life Sciences
13 Global 3D Bioprinting for Tissue and Organ Regeneration Market Forecast by Region by Type and by Application
13.1 Global 3D Bioprinting for Tissue and Organ Regeneration Revenue Forecast 2023-2028
13.2 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Regions
13.3 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Type
13.4 Global 3D Bioprinting for Tissue and Organ Regeneration Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com